Supplementary Data for Beauvericin Biosynthesis in Engineered Fungal Platform

A 2026 supplementary document from figshare by Yutong Ai details the development of a fungal cell factory for beauvericin. The study reports achieving a yield of 921.24 mg/kg dry weight, the highest reported to date, using the engineered strain Emericellopsis sp. XJ1056. The work establishes a platform for heterologous production of nonribosomal peptides.

Use Cases

• Benchmarking fungal strain engineering strategies based on the described genetic toolkit and homologous recombination efficiency improvements.
• Analyzing fermentation optimization for secondary metabolite production based on the described solid medium conditions.
• Studying codon optimization effects on transcriptional efficiency and yield based on the reported results for beauvericin.
• Investigating precursor supply pathways for nonribosomal peptides based on the integration of the kivr gene described.

Strengths

• Reports specific, high-yield production metrics (921.24 mg/kg dry weight) for beauvericin.
• Describes a detailed genetic engineering methodology, including efficiency improvements from 9.4% to 50–73.68%.
• Licensed under CC-BY-4.0 for open reuse.

Limitations

• Data format is a DOCX document; column-level data structure and sample data are unavailable.
• Row count is unknown, which may limit suitability assessment for structured analysis.
• The dataset is a supplementary file; primary experimental data may be embedded in figures or text requiring extraction.

Provenance

Source

figshare, author Yutong Ai.

Collection Method

Supplementary data from a scientific study on fungal metabolic engineering.

Time Range

Study published circa 2026.

Freshness

Last updated 2026-04 16 05:24:29.

Geography

null